Scott J. Rodig
Scott J. Rodig publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as Cancer Immunotherapy and Biomarkers, Lymphoma Diagnosis and Treatment and CAR-T cell therapy research.
- World rank
- #1,821 of 7,710,434 ranked researchers
- Rank in United States
- #704 of 1,627,098
- Works
- 1,563
- Citations
- 80k
- Citations per work
- 51.2
What does Scott J. Rodig research?
Scott J. Rodig's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences73046.7%
- Medicine73046.7%
- Everything else42827.4%
- Life Sciences40525.9%
- 1Oncology25% of their works
- 2Molecular Biology14% of their works
- 3Immunology12% of their works
- 4Pathology and Forensic Medicine10% of their works
- 5Pulmonary and Respiratory Medicine7% of their works
- 6Genetics5% of their works
Research topics
Which keywords describe Scott J. Rodig's research?
The keywords of their largest research topics: Lymphoma, Rituximab, Immune Checkpoint Blockade, PD-1 and PD-L1, Classification, Molecular Profiling, Cancer Immunotherapy and Targeted Therapy.
- EGFR Mutations
- Mutational Signatures
- Natural Killer Cells
- Genomic Aberrations
- Immunity
- Chimeric Antigen Receptor
- Targeted Therapy
- Molecular Profiling
- PD-1 and PD-L1
- Rituximab
- Lymphoma
- Immune Checkpoint Blockade
- Classification
- Cancer Immunotherapy
- CAR T Cells
- Dendritic Cells
- Chronic Lymphocytic Leukemia
- NK Cell Recognition
- Cancer Genomics
- ALK Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Lymphoma2452 topics
- Rituximab2262 topics
- Immune Checkpoint Blockade2091 topic
- PD-1 and PD-L12091 topic
- Classification1631 topic
- Molecular Profiling1631 topic
- Cancer Immunotherapy1502 topics
- Targeted Therapy1102 topics
- CAR T Cells821 topic
- Chimeric Antigen Receptor821 topic
- Dendritic Cells681 topic
- Immunity681 topic
- Chronic Lymphocytic Leukemia631 topic
- Genomic Aberrations631 topic
- NK Cell Recognition611 topic
- Natural Killer Cells611 topic
- Cancer Genomics591 topic
- Mutational Signatures591 topic
- ALK Inhibitors511 topic
- EGFR Mutations511 topic
Where does Scott J. Rodig work?
Scott J. Rodig's main affiliation in the publication record is Brigham and Women's Hospital, United States.
How many publications and citations does Scott J. Rodig have?
OpenAlex counts 1,563 works and 80,092 citations for Scott J. Rodig, an h-index of 131, ranking #1,821 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Scott J. Rodig. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.